October 28, 2025

BioLife Solutions, Inc. (BLFS) Stock Analysis: A 12.34% Upside Potential in the Booming Cell and Gene Therapy Market

BioLife Solutions, Inc. (NASDAQ: BLFS) is a name that continues to attract attention in the healthcare sector, particularly within the niche of medical instruments and supplies...

Arcutis Biotherapeutics, Inc. (ARQT)

⚠️ No article content returned.

..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 63% Potential Upside for Investors

LifeStance Health Group, Inc. (NASDAQ: LFST) is a prominent player in the healthcare sector, specifically within the medical care facilities industry, focusing on providing outpatient mental..

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook with 143% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is capturing the attention of investors, especially those with an appetite for the dynamic and transformative biotech sector. With a market..

Zai Lab Limited (ZLAB) Stock Analysis: A Biotech Contender with 109% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB), the Chinese biopharmaceutical powerhouse, is making waves in the biotechnology sector with a robust portfolio of products and strategic collaborations. With..

Agios Pharmaceuticals (AGIO) Investor Outlook: Analyzing the 8.33% Potential Upside

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology industry, thanks to its innovative approach to cellular metabolism and its promising pipeline of therapeutics...

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Exploring a Potential 60% Upside

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 60.29%. With a market capitalization..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 7.86% Upside Potential in Biotechnology

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company, has been gaining attention in the biotechnology sector for its innovative approach to tackling diseases driven by..

Veracyte, Inc. (VCYT) Stock Analysis: Navigating a 14.26% Potential Upside in the Diagnostics Sector

Veracyte, Inc. (NASDAQ: VCYT) is an intriguing player in the healthcare sector, operating within the diagnostics and research industry. With a market capitalization of $2.83 billion,..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 36% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare management sector, has been capturing investor attention due to its robust growth metrics and potential..

Biohaven Ltd. (BHVN) Stock Analysis: Unpacking a 163.56% Potential Upside for Savvy Investors

Biohaven Ltd. (NYSE: BHVN) has captured the attention of the investment community with its robust portfolio of innovative therapies spanning various critical areas such as neuroscience,..

ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a 283% Upside Potential in the Biotech Sector

Investors eyeing the biotechnology sector may want to take a closer look at ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage biotech company with a focus on innovative..

Liquidia Corporation (LQDA) Stock Analysis: Navigating 62% Upside Potential Amidst Robust Revenue Growth

Liquidia Corporation (NASDAQ: LQDA) continues to capture the attention of investors with its promising growth trajectory and impressive 62.08% potential upside, according to analyst ratings. This..

AdaptHealth Corp. (AHCO) Stock Analysis: Navigating a 38% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a significant player in the healthcare sector, primarily focuses on distributing home medical equipment (HME) and associated services across the United States...

SS Innovations International (SSII) Stock Analysis: A Healthcare Innovator with 121.80% Revenue Growth

SS Innovations International, Inc. (SSII) stands out as a dynamic player in the healthcare sector, specifically within the medical devices industry. Based in Gurugram, India, this..

Kestra Medical Technologies (KMTS) Stock Analysis: A 51.5% Revenue Growth Powering the Healthcare Innovator

Kestra Medical Technologies, Ltd. (KMTS), a forward-thinking player in the healthcare sector, has been garnering significant attention for its remarkable revenue growth and innovative approach to..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Navigating a High Upside Potential with 89.75% Gain

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biotechnology company specializing in innovative eye condition therapies, is making waves in the healthcare sector with its intriguing financial metrics..

Adaptive Biotechnologies (ADPT) Stock Analysis: A Biotech Pioneer with a 36% Revenue Growth Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a notable player in the biotechnology sector, has captured investor attention with its innovative approach to diagnostics and treatment. This Seattle-based..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 48.46% Potential Upside in Biotech Innovation

Vericel Corporation (NASDAQ: VCEL) stands out in the healthcare sector with its pioneering efforts in cellular therapies and specialty biologic products. As a commercial-stage biopharmaceutical company..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A Biotech Gem with 31% Upside Potential

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) has emerged as a compelling player within the biotechnology sector, specifically targeting the neuroscience domain. Headquartered in Burnaby, Canada, this biopharmaceutical..

Search

Funds

October 28, 2025

Search

Funds

October 28, 2025

FTSE 100

Funds